Sunesis Pharmaceuticals - Inspired to Make a Difference in Cancer Patients Lives.
Sunesis is a biopharmaceutical company focused on the development and commercialization of our pipeline of new oncology therapeutics for the potential treatment of solid and hematologic cancers.

We have built a highly experienced cancer drug development organization committed to advancing our lead product candidate, QINPREZO™ (vosaroxin), as well as our emerging kinase inhibitor pipeline, through:

Delivering on our Promise

Develop and commercialize medicines with significant potential to improve cancer care

Leadership

Experience and passion to build a company focused on improving the lives of people with cancer

Commitment

We are in this business because we believe we can make a difference. Read about our commitment to improving the lives of people with cancer and their loved ones.